blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4026845

EP4026845 - ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  20.01.2023
Database last updated on 03.10.2024
FormerThe application has been published
Status updated on  10.06.2022
Most recent event   Tooltip18.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Zoetis Services LLC
10 Sylvan Way
Parsippany, NJ 07054 / US
[2022/28]
Inventor(s)01 / GEARING, David
Victoria / AU
 [2022/28]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2022/28]
Application number, filing date21207684.808.05.2012
[2022/28]
Priority number, dateUS201161483488P06.05.2011         Original published format: US 201161483488 P
US201161531439P06.09.2011         Original published format: US 201161531439 P
[2022/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4026845
Date:13.07.2022
Language:EN
[2022/28]
Search report(s)(Supplementary) European search report - dispatched on:EP13.06.2022
ClassificationIPC:C07K16/22, C07K16/46, A61P25/04, A61K39/00
[2022/28]
CPC:
C07K16/22 (EP,GB,KR,RU); A61K38/17 (KR); A61K38/18 (KR);
A61K39/395 (KR); A61K47/42 (KR); A61K48/00 (KR);
A61P17/04 (EP); A61P19/02 (EP); A61P25/00 (EP);
A61P25/04 (EP); A61P29/00 (EP); A61P35/00 (EP);
C07K14/435 (KR); C07K14/475 (KR); C07K16/18 (KR);
C07K16/28 (KR); C07K16/46 (KR); C07K16/467 (EP,GB,RU);
A01K2207/20 (EP); A01K2227/10 (EP); A01K2267/0368 (EP);
A61K2039/505 (EP); A61K38/00 (EP); C07K2317/24 (EP,GB);
C07K2317/567 (EP); C07K2317/76 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/08]
Former [2022/28]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ANTIKÖRPER GEGEN NERVENWACHSTUMSFAKTOR UND VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON[2022/28]
English:ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME[2022/28]
French:ANTICORPS CONTRE LE FACTEUR DE CROISSANCE NEURONALE ET LEURS PROCÉDÉS DE PRÉPARATION ET D'UTILISATION[2022/28]
Examination procedure13.01.2023Amendment by applicant (claims and/or description)
13.01.2023Examination requested  [2023/08]
13.01.2023Date on which the examining division has become responsible
Parent application(s)   TooltipEP12723731.1  / EP2705055
EP18205428.8  / EP3498732
Fees paidRenewal fee
28.02.2022Renewal fee patent year 03
28.02.2022Renewal fee patent year 04
28.02.2022Renewal fee patent year 05
28.02.2022Renewal fee patent year 06
28.02.2022Renewal fee patent year 07
28.02.2022Renewal fee patent year 08
28.02.2022Renewal fee patent year 09
28.02.2022Renewal fee patent year 10
28.02.2022Renewal fee patent year 11
21.03.2023Renewal fee patent year 12
18.03.2024Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO03060080  (IDEXX LAB INC [US], et al);
 [A]WO2005061540  (LAY LINE GENOMICS SPA [IT], et al);
 [Y]WO2006131951  (LAY LINE GENOMICS SPA [IT], et al);
 [Y]WO2010027488  (VET THERAPEUTICS INC [US], et al);
 [AP]WO2012024650  (ABBOTT LAB [US], et al);
by applicantUS4376110
 EP0368684
 WO9222324
 US5831012
 WO9916873
 US6291158
 WO0220565
 US6582915
 US6593081
 WO2004044011
 WO2006131951
 US7250297
 US2007191272
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.